Scarica l'app Stockscreener
21.42
0.28%
0.06
Dopo l'orario di chiusura:
21.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Precedente Chiudi:
$21.36
Aprire:
$21.38
Volume 24 ore:
1.01M
Relative Volume:
0.36
Capitalizzazione di mercato:
$2.10B
Reddito:
$221.08M
Utile/perdita netta:
$-2.92M
Rapporto P/E:
-649.09
EPS:
-0.033
Flusso di cassa netto:
$5.89M
1 W Prestazione:
+0.47%
1M Prestazione:
-9.08%
6M Prestazione:
+123.82%
1 anno Prestazione:
+106.16%
Intervallo 1D:
$21.36
$21.45
Intervallo di 1 settimana:
$21.29
$21.55
Portata 52W:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Nome
Avadel Pharmaceuticals Plc
Settore
Telefono
636-449-1830
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta AVDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.42 | 2.10B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
120.98 | 52.29B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.61 | 45.27B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 42.39B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.13 | 34.18B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.30 | 21.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | Iniziato | Wells Fargo | Equal Weight |
| 2025-07-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-06-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-05 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-05 | Reiterato | Needham | Buy |
| 2024-03-05 | Reiterato | Oppenheimer | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2022-11-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-28 | Ripresa | Craig Hallum | Buy |
| 2022-05-26 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2020-07-31 | Iniziato | Oppenheimer | Outperform |
| 2020-07-21 | Iniziato | SVB Leerink | Outperform |
| 2020-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-03 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Iniziato | Stifel | Buy |
| 2020-02-26 | Iniziato | Piper Sandler | Overweight |
| 2020-01-30 | Iniziato | Craig Hallum | Buy |
| 2019-06-14 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mostra tutto
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 1.9% stake in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals - Investing.com India
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com India
Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Market Moves: How higher bond yields impact Avadel Pharmaceuticals plc AWK stockPrice Action & Daily Chart Pattern Signal Reports - moha.gov.vn
Avadel Pharmaceuticals PLC. $AVDL Position Lowered by Gendell Jeffrey L - MarketBeat
AWM Investment Company Inc. Purchases 275,189 Shares of Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plcAVDL - PR Newswire
Goldman Sachs (EPT)38.5bAVADEL PHARMACEUTICALS PLC - Research Tree
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
J.P. Morgan Securities discloses position in Avadel Pharmaceuticals - Investing.com
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Citadel Group discloses 1.24% stake in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.24% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Geode Capital discloses 2.25% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Geode Capital discloses 2.25% stake in Avadel Pharmaceuticals - Investing.com India
Bank of America discloses 2% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Citadel Group discloses 1.22% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley reports trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Australia
Morgan Stanley reports trading activity in Avadel Pharmaceuticals shares - Investing.com
Citadel Group discloses 1.22% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities By Investing.com - Investing.com Nigeria
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com India
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Alkermes, Avadel Pharmaceuticals merger gets HSR clearance in US - MLex
Avadel Pharmaceuticals Acquisition by Alkermes Advances - TradingView — Track All Markets
Trium Capital discloses 1.29% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Trium Capital discloses 1.29% stake in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):